Note: Ingredients listed on restricted chemical lists
EC/CAS
79-06-1
Name of the chemical
Acrylamide
Concentration
N/A
General Information
Revision date
2008-06-11
Product name
Acrylamide IEF 40% solution, 1L
CAS No.
79-06-1
supplier name
GE Healthcare UK Ltd
Emergency telephone
1-800-424-9300
Icons in SDS
Company Information
company name
GE Healthcare UK Ltd
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
This material is considered hazardous by the OSHA Hazard Communication Standard ( 29 CFR 1910. 1200 ) Physical state Liquid. Odor Odorless. OSHA/HCS status This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Emergency overview WARNING! HARMFUL IF INHALED. CAUSES RESPIRATORY TRACT, EYE AND SKIN IRRITATION. MAY BE HARMFUL IF ABSORBED THROUGH SKIN OR IF SWALLOWED. CONTAINS MATERIAL THAT CAN CAUSE TARGET ORGAN DAMAGE. SUSPECT CANCER HAZARD - CONTAINS MATERIAL WHICH MAY CAUSE CANCER. BIRTH DEFECT HAZARD - CONTAINS MATERIAL WHICH CAN CAUSE BIRTH DEFECTS.
Precautionary statements
Do not handle until all safety precautions have been read and understood. Obtain special instructions before use. Do not breathe vapor or mist. Do not ingest. Use only with adequate ventilation. Do not eat, drink or smoke when using this product. Avoid contact with eyes, skin and clothing. Avoid prolonged contact with eyes, skin and clothing. Keep container tightly closed. Use personal protective equipment as required. Wash thoroughly after handling. Routes of entry Dermal contact. Eye contact. Inhalation. Ingestion.
Potential Acute Health Effects
Eyes Irritating to eyes. Skin Harmful in contact with skin. Irritating to skin. Inhalation Toxic by inhalation. Irritating to respiratory system. Exposure to decomposition products may cause a
Health hazards
Serious effects may be delayed following exposure Ingestion Harmful if swallowed.
Potential chronic health
effects Contains material that can cause target organ damage. Carcinogenicity Contains material which may cause cancer. Risk of cancer depends on duration and level of exposure. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
Contains material which can cause birth defects. Developmental effects No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Target organs Contains material which may cause damage to the following organs: the reproductive system, peripheral nervous system, skin, eyes, central nervous system (CNS). Inhalation Adverse symptoms may include the following: respiratory tract irritation coughing reduced fetal weight increase in fetal deaths skeletal malformations Ingestion Adverse symptoms may include the following: reduced fetal weight increase in fetal deaths skeletal malformations Skin Adverse symptoms may include the following: irritation redness reduced fetal weight increase in fetal deaths skeletal malformations Eyes Adverse symptoms may include the following: pain or irritation watering redness reduced fetal weight increase in fetal deaths skeletal malformations
Medical Conditions Generally Aggravated by Exposure
Pre-existing disorders involving any target organs mentioned in this MSDS as being at risk may be over-exposure aggravated by over-exposure to this product. See toxicological information (Section 11)